Business Insider: Ritter Pharmaceuticals Announces Issuance of New Patents for its Lactose Intolerance Treatment, RP-G28, and Provides an Update on its Path Forward into Phase 3 Ritter Pharmaceuticals Announces Issuance of New Patents for its Lactose Intolerance Treatment, RP-G28, and Provides an Update on its Path Forward into Phase 3 Los Angeles Business Journal: Ritter Pharma Raises $23 million to Test Lactose Intolerance Treatment A synthetic glue that sticks to the inside of the small intestine could form the basis of a treatment for several health conditions, including lactose intolerance, diabetes and obesity. Tests in pigs ... Market research indicates an unmet need for better lactose intolerance treatments and interest from both patients and physicians in the RP-G28 drug profile LOS ANGELES, Aug.
08, 2019 (GLOBE NEWSWIRE) ... Lactose intolerance symptoms include bloat, diarrhea, and gas shortly after eating dairy products. If you have a hard time digesting lactose, try an enzyme supplement like Lactaid before eating dairy. Lactose intolerance and malabsorption are conditions that arise from an insufficient production of lactase, the enzyme essential for the digestion of lactose in the small intestine.
lactose intolerance treatment, This enzyme ... Ritter Pharmaceuticals Inc., a Century City biotech company that develops therapies for gastrointestinal diseases, raised $23 million to fund a Phase 3 clinical trial for its lactose intolerance ... Dear Dr. Roach: I’m a 78-year-old retired medical oncologist. While in residency in New York, I got a gastrointestinal virus that left me with lactose intolerance.
lactose intolerance treatment, After a while, it improved somewhat. New Scientist: Coating our gut walls with glue could treat lactose intolerance Business Insider: Ritter Pharmaceuticals Provides Highlights from Lactose Intolerance Market Research Call
